Revenue Cycle Quality Emerges as Key Valuation Driver in Physician Practice Deals

According to a recent LinkedIn post from CERTIFY Pay, physician practice transaction activity remained robust in Q1 2026, with 79 deals reportedly closing and specialty valuation ranges such as 8–11x EBITDA for cardiology and 7–10x for orthopedics cited as market benchmarks. The post emphasizes that while multiples are familiar, investors are increasingly focusing on how those valuations are derived rather than relying purely on reported financials.

The company’s LinkedIn post highlights a shift toward deeper diligence on revenue cycle integrity, including denial rates, charge capture accuracy, payer mix stability, and documentation quality that underpins collections. According to the post, discrepancies between operational revenue data and headline financial statements are influencing adjustments to deal terms, longer diligence timelines, and in some instances halted transactions, not due to weak demand but due to perceived revenue unpredictability.

As shared in the post, revenue cycle performance is being framed less as a back-office efficiency metric and more as a direct valuation driver that can materially affect how practices are underwritten by buyers and lenders. Practices with structured, auditable billing and consistent processes are described as being viewed as more predictable and lower risk, which may support stronger multiples or smoother closing processes in a competitive private equity environment.

Within this context, the LinkedIn content positions CERTIFY Pay’s platform as aligned with these evolving investor priorities by focusing on consistent capture, validation, and tracking of claim-related revenue data. For investors, the post suggests that healthcare revenue cycle technology providers could see rising strategic relevance as tools to de-risk transactions, potentially supporting demand for solutions that enhance data transparency, auditability, and trust in financial outcomes.

If these diligence trends continue, physician practices that invest in rigorous revenue cycle management may be better positioned in future sale processes or recapitalizations, with clearer visibility into cash flow quality and fewer surprises during diligence. This dynamic could reinforce a bifurcation in valuations between practices with robust, technology-enabled revenue operations and those with less mature systems, potentially influencing capital allocation decisions across the healthcare services and health IT landscape.